125
Participants
Start Date
May 31, 2015
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
Foundation Medicine, Inc, Cambridge
Lead Sponsor
Rush University Medical Center
OTHER
Stormont-Vail Healthcare
UNKNOWN
Jefferson Medical College of Thomas Jefferson University
OTHER
The Cleveland Clinic
OTHER
Sparrow Health System
OTHER
Cancer & Hematology Centers of Western Michigan (CHCWM)
UNKNOWN
Allegheny Health Network
OTHER
St. Luke's Hospital and Health Network, Pennsylvania
OTHER
Solano Hematology Oncology
UNKNOWN
Horizon Oncology Center
UNKNOWN
Comprehensive Blood and Cancer Center
OTHER
Lancaster Cancer Center
OTHER
Western Maryland Health Center
UNKNOWN
Valley Medical Oncology
UNKNOWN
Cape Fear Valley Health System
OTHER
Tri-County Hematology Oncology
UNKNOWN
Hematology & Oncology Associates
UNKNOWN
Broome Oncology
UNKNOWN
Orchard Healthcare
UNKNOWN
Ashland Bellefonte Cancer Center
UNKNOWN
Tennessee Cancer Specialists
UNKNOWN
North Shore Hematology Oncology
UNKNOWN
Good Samaritan
UNKNOWN
Zangmeister Cancer Center
UNKNOWN
Watson clinic
UNKNOWN
Oncology Consultants
UNKNOWN
Oncology Hematology Care
UNKNOWN
Northern Westchester Hospital
OTHER
Peter MacCallum Cancer Center Trials Unit
UNKNOWN
Foundation Medicine
INDUSTRY